Compare MLYS & ESQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MLYS | ESQ |
|---|---|---|
| Founded | 2019 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 910.9M |
| IPO Year | 2023 | 2017 |
| Metric | MLYS | ESQ |
|---|---|---|
| Price | $23.61 | $106.98 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | $48.67 | ★ $120.33 |
| AVG Volume (30 Days) | ★ 1.1M | 75.5K |
| Earning Date | 03-12-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 0.75% |
| EPS Growth | ★ 37.43 | 14.20 |
| EPS | N/A | ★ 5.87 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $28.65 |
| Revenue Next Year | N/A | $4.95 |
| P/E Ratio | ★ N/A | $18.16 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.44 | $69.14 |
| 52 Week High | $47.65 | $119.86 |
| Indicator | MLYS | ESQ |
|---|---|---|
| Relative Strength Index (RSI) | 36.30 | 50.75 |
| Support Level | $12.98 | $91.62 |
| Resistance Level | $31.09 | $112.17 |
| Average True Range (ATR) | 1.56 | 3.89 |
| MACD | -0.06 | 0.36 |
| Stochastic Oscillator | 12.94 | 50.92 |
Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.
Esquire Financial Holdings Inc is a financial holding company operating as a full service commercial bank. It serves the financial needs of the litigation industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The bank offers tailored financial and payment processing solutions to the litigation community and their clients as well as dynamic and flexible payment processing solutions to small business owners. It operates in one operating segment, that of community banking.